Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2016

01-08-2016 | Editorial

Getting to the ‘Why’ of Behavior Change

Author: Mitchell D. Feldman, MD, MPhil

Published in: Journal of General Internal Medicine | Issue 8/2016

Login to get access

Excerpt

In his book Start with Why: How Great Leaders Inspire Everyone to Take Action 1 and in his well known TED talk, Simon Sinek, leadership author and consultant, argues that what distinguishes great leaders and organizations is their focus on the ‘why’ of the work and not just on the ‘what’ and the ‘how’. In fact, great leaders and organizations start with the ‘why’ and then move to the how and the what—while more conventional organizations move the other way; they start with the ‘what’ and then move to the ‘how’ and may never get around to the ‘why’. …
Literature
1.
Sinek S. Start with why: how great leaders inspire everyone to take action. New York, NY: Penguin; 2009.
2.
Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med. doi: 10.​1007/​s11606-016-3685-3.
3.
4.
Thornton JD, Sullivan C, Albert JM, et al. Effects of a video on organ donation consent among primary care patients: a randomized controlled trial. J Gen Intern Med. doi: 10.​1007/​s11606-016-3630-5
Metadata
Title
Getting to the ‘Why’ of Behavior Change
Author
Mitchell D. Feldman, MD, MPhil
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3752-9

Other articles of this Issue 8/2016

Journal of General Internal Medicine 8/2016 Go to the issue

Capsule Commentary

Capsule Commentary on Patel et al., Change in Length of Stay and Readmissions Among Hospitalized Medical Patients After Inpatient Medicine Service Adoption of Mobile Secure Text Messaging

Review Paper

For the General Internist: A Summary of Key Innovations in Medical Education

Frontline Account: Physician Partners

Frontline Account: Physician Partners: An Antidote to the Electronic Health Record

Original Research

Social Function and Cognitive Status: Results from a US Nationally Representative Survey of Older Adults

Healing Arts: Materia Medica

Breathe

Original Research

Change In Length of Stay and Readmissions among Hospitalized Medical Patients after Inpatient Medicine Service Adoption of Mobile Secure Text Messaging
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits